JointHealth™ express December 2, 2015
What has ACE done for you lately?
Here's what we've been working on this Fall
Canada's Best Workplaces for Employees Living with Arthritis
Congratulations to Simon Fraser University, L'Oréal Canada and High Liner Foods for winning the 2015 Canada's Best Workplaces for Employees Living with Arthritis award.
Here are some best practices identified during our interview process:
We featured Best Workplaces in our Oct/Nov JointHealth Monthly as well as an editorial on Manulife's Drug Watch policy. ACE has led the arthritis community's response to Manulife's new policy, which sets a dangerous precedent for arthritis consumers and runs contrary to known scientific evidence. ACE has submitted letters to the editors at Benefits Canada and the Globe&Mail in response to their coverage of the Manulife announcement.
Patient input Submission
ACE sent out a call for patient input and submitted a "Your Voice" submission in British Columbia for apremilast for psoriatic arthritis. We are currently looking for patient input for CADTH's Request for Advice on the Canadian Drug Expert Committee's recommendations for denosumab for osteoporosis. Please email your input to feedback@jointhealth.org by Friday, December 11, 2015.
What has ACE done for you lately?
Here's what we've been working on this Fall
Canada's Best Workplaces for Employees Living with Arthritis
Congratulations to Simon Fraser University, L'Oréal Canada and High Liner Foods for winning the 2015 Canada's Best Workplaces for Employees Living with Arthritis award.
Here are some best practices identified during our interview process:
- Simon Fraser University provides a disability management program, disability accommodation policy, and health and wellness services and workshops to employees.
- L'Oréal Canada offers employees flexible hours, flexible health benefits plan, telecommuting, compressed work weeks and early Friday closings on winter and summer.
- High Liner Foods offers employees progressive employee/family assistance programs, including dieticians, smoking cessation products, and allow employees to participate in their own benefit plan design.
We featured Best Workplaces in our Oct/Nov JointHealth Monthly as well as an editorial on Manulife's Drug Watch policy. ACE has led the arthritis community's response to Manulife's new policy, which sets a dangerous precedent for arthritis consumers and runs contrary to known scientific evidence. ACE has submitted letters to the editors at Benefits Canada and the Globe&Mail in response to their coverage of the Manulife announcement.
Patient input Submission
ACE sent out a call for patient input and submitted a "Your Voice" submission in British Columbia for apremilast for psoriatic arthritis. We are currently looking for patient input for CADTH's Request for Advice on the Canadian Drug Expert Committee's recommendations for denosumab for osteoporosis. Please email your input to feedback@jointhealth.org by Friday, December 11, 2015.
Arthritis Consumer Experts
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealth™ information and education programs.